Diabetes managment platform
Glooko has raised €31M across 1 funding round from 7 investors, most recently a Series C round in Jun 2017. Based in Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-06-27 | Series C | €31M |
| Canaan Partners,Georgian Partners,Insulet,Mayo Clinic,Medtronic,Samsung NEXT+1 more |
| View deal → |
